A highly efficacious live attenuated mumps virus–based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike

With the rapid increase in SARS-CoV-2 cases in children, a safe and effective vaccine for this population is urgently needed. The MMR (measles/mumps/rubella) vaccine has been one of the safest and most effective human vaccines used in infants and children since the 1960s. Here, we developed live att...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuexiu, Lu, Mijia, Mahesh, K C, Kim, Eunsoo, Shamseldin, Mohamed M., Ye, Chengjin, Dravid, Piyush, Chamblee, Michelle, Park, Jun-Gyu, Hall, Jesse M., Trivedi, Sheetal, Chaiwatpongsakorn, Supranee, Kenny, Adam D., Murthy, Satyapramod Srinivasa, Sharma, Himanshu, Liang, Xueya, Yount, Jacob S., Kapoor, Amit, Martinez-Sobrido, Luis, Dubey, Purnima, Boyaka, Prosper N., Peeples, Mark E., Li, Jianrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388148/
https://www.ncbi.nlm.nih.gov/pubmed/35895717
http://dx.doi.org/10.1073/pnas.2201616119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388148/
https://www.ncbi.nlm.nih.gov/pubmed/35895717
http://dx.doi.org/10.1073/pnas.2201616119

Ejemplares similares